Neuronal (N)-type Ca2ϩ channel-selective -conotoxins have emerged as potential new drugs for the treatment of chronic pain. In this study, two new -conotoxins, CVIE and CVIF, were discovered from a Conus catus cDNA library. Both conopeptides potently displaced 125 I-GVIA binding to rat brain membranes. In Xenopus laevis oocytes, CVIE and CVIF potently and selectively inhibited depolarizationactivated Ba 2ϩ currents through recombinant N-type (␣1 B-b / ␣ 2 ␦1/ 3 ) Ca 2ϩ channels. Recovery from block increased with membrane hyperpolarization, indicating that CVIE and CVIF have a higher affinity for channels in the inactivated state. The link between inactivation and the reversibility of -conotoxin action was investigated by creating molecular diversity in  subunits: N-type channels with  2a subunits almost completely recovered from CVIE or CVIF block, whereas those with  3 subunits exhibited weak recovery, suggesting that reversibility of the -conotoxin block may depend on the type of -subunit isoform. In rat dorsal root ganglion sensory neurons, neither peptide had an effect on low-voltageactivated T-type channels but potently and selectively inhibited high voltage-activated N-type Ca 2ϩ channels in a voltage-dependent manner. In rat spinal cord slices, both peptides reversibly inhibited excitatory monosynaptic transmission between primary afferents and dorsal horn superficial lamina neurons. Homology models of CVIE and CVIF suggest that -conotoxin/voltage-gated Ca 2ϩ channel interaction is dominated by ionic/electrostatic interactions. In the rat partial sciatic nerve ligation model of neuropathic pain, CVIE and CVIF (1 nM) significantly reduced allodynic behavior. These N-type Ca 2ϩ channel-selective -conotoxins are therefore useful as neurophysiological tools and as potential therapeutic agents to inhibit nociceptive pain pathways.